Published on: Mar 11, 2026
Researchers at the University of Gothenburg have identified a stress-response protein, ATF4, associated with a higher risk of metastasis and recurrence in Lung Cancer. The findings, published in Nature, provide new insights into how aging influences cancer progression and may support more precise treatment strategies, particularly for older patients.
To better understand the impact of aging on lung cancer, researchers compared tumors in young and old mice and analyzed clinical data from nearly 1,000 patients in the Swedish regions of Halland and Västra Götaland. They found that tumors in older individuals often grow more slowly but are more likely to have already spread to other organs at the time of diagnosis.
The study revealed that aging can alter tumor biology by allowing cancer cells to hijack the body’s stress-response system. ATF4 plays a key role in this process by enabling cancer cells to reprogram their metabolism, which increases their ability to metastasize. Higher ATF4 levels were also linked to poorer survival and a greater risk of recurrence in patients with Lung Adenocarcinoma.
These findings suggest that targeting ATF4 or related metabolic pathways could open the door to new precision medicine approaches and more effective therapies for specific patient groups, especially older individuals with aggressive lung cancer.
Back to News
Meet peers and build meaningful connections with experts and industry leaders.
Learn from speakers through scientific sessions, keynotes, and practical workshops.
Capture insights to shape your research, roadmap, and future collaborations.
Grow your impact by sharing work and engaging with the global community.